Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-EGFR&LGR5, MCLA-158 Vector   (CAT#: GTVCR-WQ1852MR)

This product GTVCR-WQ1852MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting EGFR&LGR5. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Homo sapiens
RefSeq NM_001346897.2; NM_001277226.2
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 1956; 8549
UniProt ID Q504U8; O75473
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-EGFR&LGR5, MCLA-158 Vector (GTVCR-WQ1852MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ2588MR IVTScrip™ pT7-VEE-mRNA-Anti-MAPT, UCB-0107 Vector Vector UCB-0107
GTVCR-WQ654MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL6R, BCD-089 Vector Vector BCD-089
GTVCR-WQ1672MR IVTScrip™ pSP6-VEE-mRNA-Anti-env, KD-247 Vector Vector KD-247
GTVCR-WQ1858MR IVTScrip™ pSP6-VEE-mRNA-Anti-CSF1, MCS-110 Vector Vector MCS-110
GTVCR-WQ1920MR IVTScrip™ pT7-VEE-mRNA-Anti-ERBB3, MEHD7945A Vector Vector MEHD7945A
GTVCR-WQ2326MR IVTScrip™ pSP6-VEE-mRNA-Anti-PDGFRB, REGN-2176 Vector Vector REGN-2176
GTVCR-WQ1265MR IVTScrip™ pSP6-VEE-mRNA-Anti-CLDN18, GC-182 Vector Vector GC-182
GTVCR-WQ1041MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD40, CP-870893 Vector Vector CP-870893
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.